Literature DB >> 28276951

Successful treatment with ustekinumab for corticosteroid- and immunosuppressant-resistant Takayasu's arteritis.

R Yachoui1, M Kreidy2, M Siorek3, R Sehgal1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28276951     DOI： 10.1080/03009742.2017.1278788

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN： 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  5 in total

Review 1.  Large-vessel vasculitis.

Authors:  Dan Pugh; Maira Karabayas; Neil Basu; Maria C Cid; Ruchika Goel; Carl S Goodyear; Peter C Grayson; Stephen P McAdoo; Justin C Mason; Catherine Owen; Cornelia M Weyand; Taryn Youngstein; Neeraj Dhaun
Journal:  Nat Rev Dis Primers       Date:  2022-01-06       Impact factor: 65.038

Review 2.  Leveraging Genetic Findings for Precision Medicine in Vasculitis.

Authors:  Marialbert Acosta-Herrera; Miguel A González-Gay; Javier Martín; Ana Márquez
Journal:  Front Immunol       Date:  2019-08-02       Impact factor: 7.561

3.  Successful treatment with the IL12/IL23 antagonist ustekinumab in a patient with refractory Takayasu arteritis.

Authors:  Sebastian-Jonas Saur; Marius Horger; Jörg Henes
Journal:  Rheumatol Adv Pract       Date:  2021-01-20

4.  Pathogenesis of liver injury in Takayasu arteritis: advanced understanding leads to new horizons.

Authors:  Kai Kang; Yue Sun; Yi Ling Li; Bing Chang
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

Review 5.  The Th17 Pathway in Vascular Inflammation: Culprit or Consort?

Authors:  Marie Robert; Pierre Miossec; Arnaud Hot
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.